OH Pharmaceutical

Executive Summary

OH Pharmaceutical is a U.S.-based private company focused on drug delivery and small molecules, headquartered in San Diego, CA. Founded in 2018, the company develops and markets the UK Injection Kit—a ready-to-use sterile injection system—and the Kegel Q, a pelvic floor wellness device. Additionally, OH Pharmaceutical offers business development, sourcing, and market entry services for healthcare companies entering the U.S. market. While the company has commercial products, it remains early-stage with limited public information on funding, revenue, or pipeline. The dual focus on drug delivery devices and wellness products may provide diversification, but the lack of disclosed clinical data or regulatory milestones suggests a high-risk profile. Future growth likely hinges on adoption of its injection kit and expansion of the Kegel Q device into broader markets. Without significant partnerships or funding rounds, the company's trajectory is uncertain.

Upcoming Catalysts (preview)

• TBDUK Injection Kit Commercial Expansion60% success
• TBDKegel Q FDA Clearance or 510(k) Filing50% success
• TBDStrategic Partnership or Distribution Agreement40% success